|
27 Feb 2007 |
Novelix Announces Licensing of Cancer Compound to AOP Orphan Pharmaceuticals
|
|
27 Feb 2007 |
Trius Therapeutics Completes $20 Million Series A Financing and Names CEO
|
|
24 Feb 2007 |
Focetria(R) pandemic influenza vaccine receives positive European Union regulatory agency opinion supporting approval
|
|
23 Feb 2007 |
TorreyPines Therapeutics and Eisai Co., Ltd. Extend Alzheimer's Disease Collaboration Agreement
|
|
23 Feb 2007 |
Teva Announces Approval of Rabeprazole Sodium Delayed-Release Tablets
|
|
23 Feb 2007 |
Ikaria Inc. And Investor Group To Acquire INO Therapeutics In $670 Million Cash And Stock Merger, Creating A World Leader In Critical Care Therapeutics
|
|
23 Feb 2007 |
Bedford Laboratories receives FDA approval for Methylprednisolone Sodium Succinate for Injection, USP
|
|
22 Feb 2007 |
TransTech Pharma, Inc. obtains exclusive licence to glucokinase activator programme for the treatment of diabetes from Novo Nordisk
|
|
22 Feb 2007 |
Breakthrough oral delivery for arthritis sufferers
|
|
22 Feb 2007 |
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
|
|
22 Feb 2007 |
Orthovita Announces Completion of Patient Enrollment in Its U.S. Pivotal Clinical Study for the Use of CORTOSS(R) in the Treatment of Vertebral Compression Fractures
|
|
22 Feb 2007 |
Orthovita Announces Completion of Patient Enrollment in Its U.S. Pivotal Clinical Study for the Use of CORTOSS(R) in the Treatment of Vertebral Compression Fractures
|
|
22 Feb 2007 |
Pre-Clinical Study of Novavax's Seasonal Influenza Vaccine Published in Journal 'Vaccine'
|
|
22 Feb 2007 |
Allegiance Equity Corporation Announces Positive Results of In Vitro Studies and an Open Label Trial for Relieva(R) in Treating Atopic Dermatitis
|
|
22 Feb 2007 |
Access Pharmaceuticals Signs Letter Of Intent To Acquire Somanta Pharmaceuticals, Inc.
|
|
21 Feb 2007 |
Bentley Announces Approval and Expansion of Its Nasulin Phase II Studies in India
|
|
21 Feb 2007 |
New River Pharmaceuticals to be Acquired by Shire plc for $64 per Share
|
|
21 Feb 2007 |
Cyberkinetics Files to Market Andara(TM) OFS(TM) Therapy for Acute Spinal Cord Injury under Humanitarian Device Exemption
|
|
21 Feb 2007 |
Roche and GSK agree on two transactions
|
|
21 Feb 2007 |
Hybrigenics Focuses its Research on Inhibitors of Ubiquitin-Specific Proteases in Cancer
|
|
21 Feb 2007 |
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
|
|
21 Feb 2007 |
Genfit Extends Its Drug Discovery Strategic Alliances with Sanofi-Aventis and Solvay
|
|
20 Feb 2007 |
Entelos and Organon Extend Research Agreement
|
|
17 Feb 2007 |
OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
|
|
17 Feb 2007 |
InSite Vision Announces License Agreement With Inspire Pharmaceuticals
|
